$0.73 EPS Expected for Colgate-Palmolive (NYSE:CL) This Quarter

Wall Street analysts expect that Colgate-Palmolive (NYSE:CLGet Rating) will announce earnings of $0.73 per share for the current fiscal quarter, according to Zacks. Six analysts have provided estimates for Colgate-Palmolive’s earnings. The lowest EPS estimate is $0.69 and the highest is $0.81. Colgate-Palmolive posted earnings per share of $0.80 during the same quarter last year, which would indicate a negative year over year growth rate of 8.8%. The business is scheduled to report its next earnings results on Monday, January 1st.

According to Zacks, analysts expect that Colgate-Palmolive will report full-year earnings of $3.08 per share for the current financial year, with EPS estimates ranging from $2.99 to $3.29. For the next financial year, analysts expect that the firm will post earnings of $3.38 per share, with EPS estimates ranging from $3.27 to $3.50. Zacks’ EPS calculations are a mean average based on a survey of sell-side research analysts that that provide coverage for Colgate-Palmolive.

Colgate-Palmolive (NYSE:CLGet Rating) last released its quarterly earnings data on Friday, April 29th. The company reported $0.74 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.74. Colgate-Palmolive had a net margin of 11.70% and a return on equity of 296.77%. The company had revenue of $4.40 billion during the quarter, compared to the consensus estimate of $4.40 billion. During the same quarter in the prior year, the firm posted $0.80 earnings per share. Colgate-Palmolive’s revenue for the quarter was up 1.3% on a year-over-year basis.

Several research firms have issued reports on CL. Morgan Stanley upped their price objective on shares of Colgate-Palmolive from $90.00 to $91.00 and gave the company an “equal weight” rating in a research note on Monday, January 31st. Citigroup upped their price objective on shares of Colgate-Palmolive from $83.00 to $86.00 and gave the company a “neutral” rating in a research note on Monday, January 31st. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of Colgate-Palmolive from $91.00 to $88.00 in a research note on Monday, May 2nd. TheStreet raised shares of Colgate-Palmolive from a “c+” rating to a “b” rating in a report on Friday, April 29th. Finally, The Goldman Sachs Group reduced their target price on shares of Colgate-Palmolive from $104.00 to $95.00 in a report on Tuesday, March 29th. Two analysts have rated the stock with a sell rating, thirteen have given a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $85.19.

In other Colgate-Palmolive news, VP Philip G. Shotts sold 10,000 shares of the firm’s stock in a transaction on Monday, May 16th. The shares were sold at an average price of $78.52, for a total transaction of $785,200.00. Following the completion of the transaction, the vice president now directly owns 46,094 shares of the company’s stock, valued at approximately $3,619,300.88. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider John W. Kooyman sold 19,683 shares of the firm’s stock in a transaction on Monday, May 16th. The stock was sold at an average price of $78.49, for a total transaction of $1,544,918.67. Following the transaction, the insider now directly owns 7,007 shares of the company’s stock, valued at $549,979.43. The disclosure for this sale can be found here. Insiders own 0.32% of the company’s stock.

Hedge funds and other institutional investors have recently bought and sold shares of the company. Horan Securities Inc. bought a new stake in Colgate-Palmolive in the 4th quarter valued at about $30,000. Core Alternative Capital raised its position in shares of Colgate-Palmolive by 924.3% during the 1st quarter. Core Alternative Capital now owns 379 shares of the company’s stock worth $29,000 after buying an additional 342 shares in the last quarter. Carl Stuart Investment Advisor Inc. bought a new stake in shares of Colgate-Palmolive during the 1st quarter worth about $30,000. TAP Consulting LLC bought a new stake in shares of Colgate-Palmolive during the 4th quarter worth about $40,000. Finally, Widmann Financial Services Inc. bought a new stake in shares of Colgate-Palmolive during the 4th quarter worth about $42,000. 78.12% of the stock is owned by institutional investors and hedge funds.

NYSE CL traded up $0.70 during trading hours on Friday, hitting $78.86. The company had a trading volume of 2,742,337 shares, compared to its average volume of 5,472,354. The company has a debt-to-equity ratio of 10.42, a quick ratio of 0.67 and a current ratio of 1.09. Colgate-Palmolive has a 1-year low of $72.20 and a 1-year high of $85.61. The company has a market cap of $66.08 billion, a PE ratio of 32.59, a price-to-earnings-growth ratio of 5.02 and a beta of 0.56. The business has a 50 day moving average of $77.89 and a 200-day moving average of $79.15.

Colgate-Palmolive announced that its board has initiated a stock buyback program on Thursday, March 10th that permits the company to buyback $5.00 billion in outstanding shares. This buyback authorization permits the company to buy up to 8.1% of its shares through open market purchases. Shares buyback programs are often a sign that the company’s board of directors believes its stock is undervalued.

The company also recently declared a quarterly dividend, which was paid on Friday, May 13th. Investors of record on Thursday, April 21st were paid a dividend of $0.47 per share. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.45. The ex-dividend date of this dividend was Wednesday, April 20th. This represents a $1.88 annualized dividend and a yield of 2.38%. Colgate-Palmolive’s payout ratio is 77.69%.

About Colgate-Palmolive (Get Rating)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

See Also

Get a free copy of the Zacks research report on Colgate-Palmolive (CL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.